Search by Drug Name or NDC

    NDC 70954-0034-20 Acetazolamide 250 mg/1 Details

    Acetazolamide 250 mg/1

    Acetazolamide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is ACETAZOLAMIDE.

    Product Information

    NDC 70954-0034
    Product ID 70954-034_a304c648-f1bf-468d-a704-f4d72216f7a0
    Associated GPIs 37100010000310
    GCN Sequence Number 008166
    GCN Sequence Number Description acetazolamide TABLET 250 MG ORAL
    HIC3 R1E
    HIC3 Description CARBONIC ANHYDRASE INHIBITORS
    GCN 34722
    HICL Sequence Number 003641
    HICL Sequence Number Description ACETAZOLAMIDE
    Brand/Generic Generic
    Proprietary Name Acetazolamide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acetazolamide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name ACETAZOLAMIDE
    Labeler Name ANI Pharmaceuticals, Inc.
    Pharmaceutical Class Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210588
    Listing Certified Through 2024-12-31

    Package

    NDC 70954-0034-20 (70954003420)

    NDC Package Code 70954-034-20
    Billing NDC 70954003420
    Package 1000 TABLET in 1 BOTTLE (70954-034-20)
    Marketing Start Date 2019-10-17
    NDC Exclude Flag N
    Pricing Information N/A